Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase II, Randomized, Double-blind, Active-controlled, Dose-escalation Study to Determine the Maximum Well-tolerated Dose of Ropinirole Controlled-release (CR) in Parkinson's Disease Patients Not Receiving Other Dopaminergic Therapies
Slevin, John
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
9/1/00
→
9/1/02
Funding
Parexel International Co:
$9,530.00
View all
View less